Mintu Turakhia MD MS
Stanford, California, United States
4K followers
500+ connections
About
- Internationally recognized cardiac electrophysiologist, researcher, executive, and…
Activity
-
AI is changing the world and if you want to get excited about being a part of the current Digital Health Revolution and tackle heart disease, the #1…
AI is changing the world and if you want to get excited about being a part of the current Digital Health Revolution and tackle heart disease, the #1…
Liked by Mintu Turakhia MD MS
-
Gilead is proud to partner with the Stanford Center for Digital Health. Congratulations to the 2024-2025 Digital Health Scholars.
Gilead is proud to partner with the Stanford Center for Digital Health. Congratulations to the 2024-2025 Digital Health Scholars.
Liked by Mintu Turakhia MD MS
-
Every once in a while a team comes together in such a way that you can tell something special is happening. That's Heartbeat Health right now --…
Every once in a while a team comes together in such a way that you can tell something special is happening. That's Heartbeat Health right now --…
Liked by Mintu Turakhia MD MS
Experience
Education
Licenses & Certifications
-
Cardiac Electrophysiology, Cardiovascular Medicine, Internal Medicine
American Board of Internal Medicine
Volunteer Experience
-
HRX - Founding Co-Chair
Heart Rhythm Society
- 1 year 3 months
Health
Founding chair of Heart Rhythm Society's flagship digital health meeting. Led team to architect program, content, format, $1M fundraising, and marketing. First meeting generating 500 attendees and is now a recurring, marquee event.
Publications
-
Defining a Mobile Health Roadmap for Cardiovascular Health and Disease
Journal of the American Heart Association
AHA mHealth roadmap
-
Reduced Mortality Associated With Quadripolar Compared to Bipolar Left Ventricular Leads in Cardiac Resynchronization Therapy
JACC: Clinical Electrophysiology
-
Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
Clin Cardiol.
Little is known about the use of guideline-directed medical therapy (GDMT) in outpatients with heart failure with reduced left ventricular ejection fraction (HFrEF; ≤40%) in India. Our objective was to understand the use of GDMT in outpatients with HFrEF in India. The Practice Innovation And Clinical Excellence (PINNACLE) India Quality Improvement Program (PIQIP) is a registry for cardiovascular quality improvement in India supported by the American College of Cardiology Foundation. Between…
Little is known about the use of guideline-directed medical therapy (GDMT) in outpatients with heart failure with reduced left ventricular ejection fraction (HFrEF; ≤40%) in India. Our objective was to understand the use of GDMT in outpatients with HFrEF in India. The Practice Innovation And Clinical Excellence (PINNACLE) India Quality Improvement Program (PIQIP) is a registry for cardiovascular quality improvement in India supported by the American College of Cardiology Foundation. Between January 2008 and September 2014, we evaluated documentation of use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) and β-blockers, or both, among outpatients with HFrEF seeking care in 10 centers enrolled in the PIQIP registry. Among 75 639 patients in the PIQIP registry, 34 995 had EF reported, and 15 870 had an EF ≤40%. The mean age was 56 years; 23% were female. Hypertension, diabetes, coronary artery disease, and myocardial infarction were present in 37%, 23%, 27%, and 17%, respectively. Use of ACEIs/ARBs, β-blockers, and both were documented in 33.5%, 34.9%, and 29.6% of patients, respectively. The documentation of GDMT was higher in men, in patients age ≥65 years, and in those with presence of hypertension, diabetes, or coronary artery disease. Documentation of GDMT gradually increased over the study period. Among patients enrolled in the PIQIP registry, about two-thirds of patients with EF ≤40% did not have documented receipt of GDMT. This study is an initial step toward improving adherence to GDMT in India and highlights the feasibility of examining quality of care in HFrEF in a resource-limited setting.
Languages
-
Spanish
-
-
French
-
-
Gujarati
-
-
Hindi
-
More activity by Mintu
-
Cardiological Society of India (CSI) is holding its mid-term NIC(National Interventional Council) meeting at Chennai Trade Centre from 5th to 7th…
Cardiological Society of India (CSI) is holding its mid-term NIC(National Interventional Council) meeting at Chennai Trade Centre from 5th to 7th…
Liked by Mintu Turakhia MD MS
-
We're pleased to announce Stanford Center for Digital Health's 2024-2025 Digital Health Scholars! - Daniel Seung Kim - Tugce Akcan - Jiyeong…
We're pleased to announce Stanford Center for Digital Health's 2024-2025 Digital Health Scholars! - Daniel Seung Kim - Tugce Akcan - Jiyeong…
Liked by Mintu Turakhia MD MS
-
From Happitech to AliveCor to Apple Watch to HeartBeam Inc. (NASDAQ: BEAT) (once FDA cleared) to patches such as those from SmartCardia, Bardy…
From Happitech to AliveCor to Apple Watch to HeartBeam Inc. (NASDAQ: BEAT) (once FDA cleared) to patches such as those from SmartCardia, Bardy…
Liked by Mintu Turakhia MD MS
-
There are stars and then there are supergiant stars. Euan is the latter. We are fortunate and thrilled that Euan will succeed Bob Harrington (another…
There are stars and then there are supergiant stars. Euan is the latter. We are fortunate and thrilled that Euan will succeed Bob Harrington (another…
Shared by Mintu Turakhia MD MS
-
We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley. We have a great future ahead!!! Dr. Ashley becomes…
We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley. We have a great future ahead!!! Dr. Ashley becomes…
Liked by Mintu Turakhia MD MS
-
I'm happy to share that I graduated with an MBA from the University of California, Berkeley, Haas School of Business.
I'm happy to share that I graduated with an MBA from the University of California, Berkeley, Haas School of Business.
Liked by Mintu Turakhia MD MS
-
Beyond excited to announce the launch of Go Red For Women Venture Fund, a new initiative from the American Heart Association's AHA Ventures Group to…
Beyond excited to announce the launch of Go Red For Women Venture Fund, a new initiative from the American Heart Association's AHA Ventures Group to…
Liked by Mintu Turakhia MD MS
-
Sara Bender is a iRhythm Technologies, Inc. superstar. Can’t wait to see her impact at MedtechWOMEN.
Sara Bender is a iRhythm Technologies, Inc. superstar. Can’t wait to see her impact at MedtechWOMEN.
Shared by Mintu Turakhia MD MS
-
I’ve been busy because changing the world isn’t easy.
I’ve been busy because changing the world isn’t easy.
Liked by Mintu Turakhia MD MS
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More